Thirumalai Chemicals subsidiary, TCL Specialties LLC, has commenced the first phase of commercial operations at its new manufacturing facility in West Virginia, USA, with the first sale of Maleic Anhydride (MAN). This significant milestone marks the transition from pre-commissioning activities to active commercial production, establishing the company's manufacturing footprint in the American market.

Commercial Operations Launch

The facility has successfully moved beyond the startup phase and achieved its first commercial sale, representing a critical achievement in Thirumalai Chemicals' international expansion strategy. The phased commissioning process is expected to be completed and stabilized progressively during the first half of calendar year 2026.

Facility Specifications

The West Virginia facility houses two major manufacturing plants designed to serve diverse market segments. The facility's strategic design focuses on high-capacity production to meet growing market demand in North America.

Market Applications and Strategy

Maleic Anhydride serves multiple high-growth industrial sectors, including high strength-low weight composites for housing, automotive, transport, recreational, infrastructure, and energy applications. The product also finds use in water treatment materials, coatings, additives, lubricants, and high-performance polymers. A particularly promising growth area is its application in biodegradable polymers for daily use applications, which promises dramatic demand growth for MAN.

Regional Market Positioning

From this facility, TCL Specialties LLC will cater to MAN customers in the North-Eastern and Mid-West US markets, along with other regional markets that are presently underserved. This strategic positioning enables the company to address market gaps while establishing a strong presence in key American industrial regions.

The successful commencement of commercial operations represents a significant step forward in Thirumalai Chemicals' growth trajectory and demonstrates the company's capability to execute complex international manufacturing projects.

Thirumalai Chemicals Limited has successfully completed its preferential share issue, allotting 18,96,614 equity shares at ₹296 per share to promoter group entities. The Fund Raising Committee of the Board approved the allotment on December 23, 2025, raising a total of ₹56.14 crore as previously planned.

Share Allotment Details

The company has completed the allotment process following overwhelming shareholder approval received earlier through postal ballot. The allotment details are summarized below:

Shareholder Approval Background

The preferential share issue had received exceptional shareholder support through postal ballot:

Major Allottees

The shares have been allocated among various promoter group entities, with the largest allocations going to:

Impact on Share Capital

The allotment has resulted in an increase in the company's issued, subscribed, and paid-up share capital. The newly allotted equity shares rank pari-passu in all respects with the existing equity shares of the company.

Financial Position Context

This capital raise comes at a time when TCL's balance sheet shows robust growth:

The successful completion of this preferential issue strengthens the company's capital base and demonstrates strong promoter confidence in the company's growth prospects. The additional funds are expected to support the company's strategic initiatives and expansion plans.